Current status of blood pressure control in patients with coronary heart disease.
10.12047/j.cjap.5599.2018.007
- Author:
Yue ZHANG
1
;
Tian-Tian WANG
1
;
Shu-Li GUO
2
;
Li-Na HAN
3
;
Li ZHANG
3
;
Xiao-Ying LI
3
;
Jin FAN
3
Author Information
1. Medical School of Chinese PLA, Beijing 100853.
2. State Key Laboratory of Intelligent Control and Decision, School of Automation, Beijing Institute of Technology, Beijing 100081.
3. Department of Cardiovascular Internal Medicine, Nanlou Branch of Chinese PLA General Hospital, Beijing 100853, China.
- Publication Type:Journal Article
- Keywords:
CABG;
PCI;
coronary heart disease;
drug;
hypertension;
lifestyle;
secondary prevention
- MeSH:
Blood Pressure;
China;
Coronary Artery Bypass;
Coronary Disease;
drug therapy;
physiopathology;
surgery;
Female;
Humans;
Life Style;
Male;
Percutaneous Coronary Intervention;
Retrospective Studies;
Treatment Outcome
- From:
Chinese Journal of Applied Physiology
2018;34(1):23-27
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the level of blood pressure control in patients with coronary heart disease (CHD) of China in order to provide guidance for the prevention and treatment of CHD.
METHODS:The patients with CHD were retrospectively collected from 2011~2014 in PLA General Hospital and Hainan Branch Hospital. Then analyzed the difference of blood pressure compliance rate between different surgical methods percutaneous coronary intervention (PCI), coronary artery bypass grafting(CABG), secondary preventive drugs(aspirin, clopidogrel, nitrates, trimetazidine, nicorandil, hypotensor, hypoglycemic, lipid-lowering drugs) and lifestyle(smoking, drinking, exercise).
RESULTS:①Effects of surgical methods on blood pressure:Male's systolic blood pressure (SBP) and diastolic blood pressure(DBP) in the CABG group were lower in the PCI group and control group, and female's DBP in the CABG group were lower in the PCI group. ②Usage rate of secondary prevention drugs:usage rate of trimetazidine, calcium antagonist, β-blockers, angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor antagonist (ARB) in hypertension group were higher than in normal blood pressure group. ③ Lifestyle condition:compliance rate of blood pressure in the smoking group was lower than that in the non smoking group. And there was no significant difference in blood pressure compliance rate among whether drinking and doing exercise or not.
CONCLUSIONS:Blood pressure control in patients with CHD was still not satisfied. Compared with PCI, CABG may be more beneficial in the control of blood pressure in patients with CHD. Smoking cessation and improving the usage rate of secondary preventive drugs are still the main means of blood pressure control.
